A Glycosylated Nitric Oxide Donor, β‐Gal‐NONOate, and its Site‐specific Antitumor Activity
- 12 July 2006
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 339 (7) , 366-371
Abstract
So far, nitric oxide (NO) donors have been applied to various aspects of antitumor therapy. To selectively sensitize tumor cells and avoid unwanted side effects, we recently synthesized a β‐galactosidase‐activatable NO‐releasing compound, β‐galactosyl‐pyrrolidinyl diazeniumdiolate (β‐Gal‐NONOate). In this study, we first verified its superiority over its parent diazeniumdiolate (NONOate) in terms of targeted intracellular NO‐releasing and antitumor activity with 9L/LacZ cells (rat glioma cell line 9L with transformed LacZ gene) in vitro. β‐Gal‐NONOate only released NO when hydrolyzed by induced β‐galactosidase in 9L/LacZ cells, which led to its more powerful cytotoxicity than that of NONOate. The results showed that β‐Gal‐NONOate produced higher NO levels than NONOate in 9L/LacZ cells at equal concentration, and hence induced optimal NO levels for antitumor activity. However, in 9L cells, β‐Gal‐NONOate showed less toxicity than NONOate. Therefore, it is demonstrated that β‐Gal‐NONOate is a site‐specific prodrug for targeting NO intracellularly as a β‐galactosidase‐sensitive NO donor, and it is also expected to be a promising probe in numerous experimental settings and a potential therapeutic drug for antitumor treatment.Keywords
This publication has 28 references indexed in Scilit:
- Effects of Different Fixatives on β-Galactosidase ActivityJournal of Histochemistry & Cytochemistry, 2002
- Glycosylated diazeniumdiolates: a novel class of enzyme-activated nitric oxide donorsTetrahedron Letters, 2001
- Novel Effects of Nitric OxideAnnual Review of Pharmacology and Toxicology, 2001
- Targeting Nitric Oxide (NO) Deliveryin Vivo. Design of a Liver-Selective NO Donor Prodrug That Blocks Tumor Necrosis Factor-α-Induced Apoptosis and Toxicity in the LiverJournal of Medicinal Chemistry, 1997
- Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cellsCancer Letters, 1997
- Growth Characteristics in the Initial Stage of Micrometastasis Formation by BacterialLacZ Gene-tagged Rat Prostatic Adenocarcinoma CellsJapanese Journal of Cancer Research, 1996
- Endothelial cell-based cytokine gene delivery inhibits 9L glioma growth in vivoBrain Research, 1996
- Carrier-mediated approaches for oral drug deliveryAdvanced Drug Delivery Reviews, 1996
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994
- Facilitated Glucose Transporters in Epithelial CellsAnnual Review of Physiology, 1993